Vimarsana
Biggest News Aggregation in the World

Page 23 - Acceleron Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acceleron Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acceleron Pharma Today - Breaking & Trending Today

New therapy for anaemic myelodysplastic cancer patients - Vimarsana News

New therapy for anaemic myelodysplastic cancer patients

Reblozyl, the first erythroid maturation agent showed increased haemoglobin in transfusion-dependant patients with myelodysplastic syndromes.

Merck Nears Breakout Point After October Surprise Good News - Vimarsana News

Merck Nears Breakout Point After October Surprise Good News

Dow component Merck (NYSE:MRK) is within 2% of a new all-time high, after rallying 7.30% in the past month. Shares closed Tuesday at $94.61

Beat the Dow Jones With This Unstoppable Dividend Stock - Vimarsana News

Beat the Dow Jones With This Unstoppable Dividend Stock

This pharmaceutical stock combines strong financials with an above-average dividend.

Source: fool.com
Decibel Therapeutics Appoints Kevin F. McLaughlin to its Board of Directors - Vimarsana News

Decibel Therapeutics Appoints Kevin F. McLaughlin to its Board of Directors

12.10.2022 - BOSTON, Oct. 12, 2022 (GLOBE NEWSWIRE) - Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced the ... Seite 1

Walden Biosciences Appoints Peter Guest Linde, M.D. as Chief Medical Officer - Vimarsana News

Walden Biosciences Appoints Peter Guest Linde, M.D. as Chief Medical Officer

Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company focused on transforming the treatment of kidney disease, today announced that